Roilides, E., Carlesse, F., Tawadrous, M., Leister-Tebbe, H., Conte, U., Raber, S., . . . Queiroz-Telles, F. (2020). Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia. Pediatr Infect Dis J.
Chicago Stili AlıntıRoilides, Emmanuel, et al. "Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia." Pediatr Infect Dis J 2020.
MLA AlıntıRoilides, Emmanuel, et al. "Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia." Pediatr Infect Dis J 2020.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..